Thermo Fisher Launches Molecular Diagnostic System for Lung Transplant Rejection Assessment
The machine learning-powered platform analyzes gene expression data from biopsies to provide molecular scores for rejection probability and tissue injury.
The machine learning-powered platform analyzes gene expression data from biopsies to provide molecular scores for rejection probability and tissue injury.
The cancer center selected the technology to support clinical and research programs, with full digital adoption planned by 2027.
Despite powerful advances in precision medicine, most doctors remain untrained in these emerging diagnostic tools.
The system automates cervical cytology with AI-powered sample preparation, imaging, and analysis...
The integration of Fujifilm's Synapse Pathology with PRECIDX optimization platform seeks to address a major barrier to digital pathology adoption in US health systems.
The ethyl alcohol assay categorization enables moderate complexity laboratories to expand drug screening capabilities on the Abbott analyzer platform.
The infrared dye antibody conjugates aim to expand human phenotyping experiments innovation and make high-parameter flow cytometry more accessible.
The DX-60 system offers 28 reportable parameters, malaria detection capabilities, and requires minimal sample volumes for testing.
Market growth driven by expanding clinical applications and regulatory innovation, with kits and reagents dominating product segments.
New instrument features StreamFocus ionization technology and AI-powered intelligence for enhanced sensitivity and efficiency in clinical laboratories.
Research-use-only assay identifies 28 urinary targets and 25 antibiotic resistance markers with same-day turnaround time.
The companies plan to create a fully automated PCR testing system for infectious disease diagnosis and treatment monitoring.
The CLIA-waived immunoassay delivers results in as fast as 10 minutes and is designed for physician offices, urgent care centers, and decentralized hospital labs.
The sharp increase in fentanyl in random drug checks suggests more workers are using the opioid after they have passed pre-employment screens.